Notch Therapeutics
0 Followers
About
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.
- Website
- Industry
- Social
Team
View all (18)
David Main
President and CEO
Kamran Alam
EVP, Finance and CFO
Gregory Block
SVP, Corporate Development
Chris Bond
SVP, Preclinical & Translational Sciences
Emily Titus
VP, Process Sciences
Timothy Key
Director, Business Operations
Zain Qureshi
Director, Accounting and Corporate Controller
Shreya Shukla
Director, Research
Steven Woodside
Senior Director, Engineering
Dan Kirouac
Senior Scientist, Systems Biology
Liz Csaszar
Director, Manufacturing
Peter Zandstra
University Professor & Canada Research Chair, Stem Cell Bioengineering, University of British Columbia and University of Toronto
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.